|
Título del proyecto |
Coordinador |
|
Multivalent chemical tools to study GPCR oligomerization |
Miriam Royo |
|
Gamma-peptides as anti–alzheimer drugs with BBB crossing properties |
Miriam Royo |
|
Reelin as a potential ADtarget |
Miriam Royo |
|
Dendritic carbosilane systems as anti-neurodegenerative agents against Parkinson’s disease |
Rafael Gómez Ramírez |
|
Neural connectivity analysis pre- and post-transcranial magnetic stimulation in patients with neurological diseases |
Roberto Hornero |
|
Development of non-invasive electrodes for long-term electroencephalography (EEG) recording with application in brain-computer interfaces |
Roberto Hornero |
|
Genetic analysis of sepsis and intraoperative neuromonitoring for the assessment of postoperative behavioral changes in children |
Roberto Hornero |
|
Neuromuscular signal analysis to decipher the reorganization of the spinal cord networks controlling the recovery of skilled hand function in rodents |
Raimon Jané |
|
Electrophysiological signal processing for the assessment of disabling neurological diseases |
Joan F. Alonso López |
|
Non invasive assessment of Autonomic Nervous System in depression |
Raquel Bailón |
|
Hyperspectral and OCT imaging of muscle for assessing muscle degeneration and dystrophia in Duchenne disease |
Olga Conde |
|
Interactive platform for early detection of neurodegenerative diseases |
José Miguel López Higuera |
|
Interactive tool for early detection of emotional impairments |
José Miguel López Higuera |
|
Development of monoclonal antibodies against C99 fragment of APP protein and study of its therapeutic properties for the Alzheimer’s disease treatment |
María Pilar Marco, Núria Pascual |
|
New hybrid nanodevices for targeting senescence-associated diseases |
Ramón Martínez Máñez |
|
Search for biomarkers of Alzheimer´s disease in serum |
Ramón Martínez Máñez |
|
Development of human iPS-derived neural cells as effective drug discovery model for Lafora´s Disease |
Ángel Raya |
|
Validating multifunctional polymeric nanoparticles as novel therapeutic vehicles for Alzheimer's Disease |
Carlos Rodríguez Abreu |
|
Nanobiotechnological approach to muscular dystrophies therapy by gene delivery based on elastin like recombinamers |
F.Javier Arias (Rodríguez Cabello) |
|
Quantification of SPECT and PET images in Parkinson’s disease and degenerative parkinsonisms |
Aida Niñerola (Setoain) |
|
Neurological mechanisms of resilience to Alzheimer´s Disease |
Juan Domingo Gispert (Setoain) |
|
Validation of a novel PET quantification technique using Monte-Carlo simulations |
Aida Niñerola (Setoain) |
|
fMRI: memories through music |
Carlos Falcón (Setoain) |
|
Validation of quantitative susceptibility mapping for cortical iron deposits quantification in Parkinson's disease |
Raúl Tudela (Setoain) |
|
Non-pharmacological techniques against the caregiver syndrome |
Jordi Aguiló (Villa) |
|
Assessment of the mental state in prevention of occupational risk |
Jordi Aguiló (Villa) |
| Cáncer | Medicina regenerativa | Enfermedades cardiovasculares | Enfermedades infecciosas |
| Enfermedades neurológicas y mentales | Enfermedades respiratorias | Oftalmología | Enfermedades hepáticas |
| Enfermedades raras | Enfermedades óseas | Otras |